JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing 2024 - Q3 Earnings Report Johnson & Johnson reported a 5% increase in sales for the third quarter, reaching $23.8 billion, driven by strong demand in its pharmaceutical division.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON